We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Positive Fecal Occult Blood Test Associated with Diabetes

By LabMedica International staff writers
Posted on 25 Jan 2017
Numerous etiologies are implicated in the complications of diabetes and a link between diabetes and the predisposition to certain cancers, including colon cancer, has been established during the last decade.

The fecal occult blood test (FOBT) is a screening method used principally for detection of colon cancer or polyps; however, the relationship between FOBT and diabetes has not been explored in detail, and therefore the association between FOBT result and glycemic status, has been assessed.

Scientists at the Kanagawa University of Human Services have carried out a cross-sectional study and enrolled 12,836 apparently healthy subjects (9,258 men and 3,578 women), aged 30 to 79 years who underwent a medical health checkup at the Saitama Health Promotion Corporation in 2012. More...
Anthropometric and laboratory tests were carried out after overnight fasting.

Serum parameters were measured using standard methods on Hitachi autoanalyzers. All subjects were classified according to their glycated hemoglobin (HbA1c) into normal (HbA1c equal to or less than 5.69%), prediabetic (HbA1c 5.7% to 6.49%) and diabetic (HbA1c equal to or greater than 6.5%) groups, regardless of whether they were being treated for diabetes. FOBT was performed automatically using a diagnostic test kit the magnetic particle agglutination method, for the detection of human hemoglobin in fecal samples. A positive FOBT was defined according to the two-day stool sampling method.

The team found that mean age and HbA1c were significantly higher in the 1,502 in the positive group than the 11,334 in negative FOBT groups. There were fewer men and current smokers in the positive FOBT group. Multivariate logistic regression analysis showed that, compared with HbA1c of less than 5.69%, HbA1c of greater than 6.5% was significantly associated with positive FOBT, independently of relevant confounders including age, sex, and past history of gastric/duodenal ulcers and colon cancer or polyp.

The authors concluded that their results indicate a significant association between diabetes and positive FOBT in a Japanese population undergoing general health screening. This supports the position that subjects with diabetes may be predisposed towards gastrointestinal cancer or may suggest the presence of microangiopathy in the gut. The study was published in the January 2017 issue of the journal Clinical Biochemistry.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Urine Analyzer
respons® UDS100
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.